Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Xeris Biopharma Holdings, Inc.

XERSNASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Jul 1, 2026Accepted Jul 1, 2026, 4:51 PM EDTFiling CIK 1652410Accession 0001950047-26-006741
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
XERIS BIOPHARMA HOLDINGS, INC.
Issuer CIK
0001867096
SEC file number
001-40880
Phone
8444455704
Person for whose account securities are to be sold
BETH HECHT
Relationships to issuer
Officer
Street
1375 West Fulton Street, Suite 1300
City
Chicago
State / country code
IL
Postal code
60607

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common49,998395,984.16172,642,05507/01/2026NASDAQMorgan Stanley Smith Barney LLC Executive Financial Services

Broker / market maker — proposed row 1, entry 1

Name
Morgan Stanley Smith Barney LLC Executive Financial Services
Street
1 New York Plaza
Street (continued)
8th Floor
City
New York
State / country code
NY
Postal code
10004

Acquisition of securities to be sold

Acquisition of securities to be sold · 3 reported rows
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common01/31/2023Restricted Stock UnitsIssuer37,409N01/31/2023N/A
Common06/30/2020Employee Stock Purchase PlanIssuer10,026N06/30/2020Cash
Common03/13/2020Open Market PurchaseIssuer2,563N03/13/2020Cash

Sales reported in the preceding three months

Sales reported in the preceding three months · 2 reported rows
SellerSecuritySale dateAmount soldGross proceeds
10b5-1 Sales for BETH HECHTCommon06/01/202616,667100,982.35
10b5-1 Sales for BETH HECHTCommon05/01/202616,667103,805.37

Seller — prior-sale row 1, entry 1

Name
10b5-1 Sales for BETH HECHT
Street
1375 West Fulton Street, Suite 1300
City
Chicago
State / country code
IL
Postal code
60607

Seller — prior-sale row 2, entry 1

Name
10b5-1 Sales for BETH HECHT
Street
1375 West Fulton Street, Suite 1300
City
Chicago
State / country code
IL
Postal code
60607

Prior-sale reporting

Nothing to report for the preceding three months
N

Remarks

The 10,026 securities to be sold were acquired upon the acquisition of employee stock purchase plan shares during the period of 06/30/2020 through 06/30/2024.

Notice signature

Notice date
07/01/2026
Signed
/s/ Beth Hecht
Plan adoption dates
08/08/2025

Company context

Current securities

Recent company filings

  1. 10-Q filingNov 5, 2026
  2. Results of Operations and Financial ConditionNov 5, 2026
  3. 4 filingNov 4, 2026
  4. 4 filingNov 4, 2026
  5. 3 filingNov 4, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.